Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/27/2010 | US20100129839 Method for in vitro diagnosis of pvl-producing staphylococcus aureus |
05/27/2010 | US20100129838 Methods for prediction of inflammatory bowel disease (ibd) using serologic markers |
05/27/2010 | US20100129837 Methods of capturing bacterial whole cells and methods of analyzing samples for bacteria |
05/27/2010 | US20100129836 System for detecting bacteria in blood, blood products, and fluids of tissues |
05/27/2010 | US20100129835 Methods for Selecting Improved Strains |
05/27/2010 | US20100129834 Autoimmune regulation of prostate cancer by annexin a3 |
05/27/2010 | US20100129833 Methods to Identify Modulators |
05/27/2010 | US20100129832 Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes |
05/27/2010 | US20100129831 Methods for diagnosing hypersensitivity reactions |
05/27/2010 | US20100129830 Label Independent Detection Biosensor Composition and Methods Thereof |
05/27/2010 | US20100129829 Use of plasma hsp90 related to malignancy |
05/27/2010 | US20100129828 Method of assaying leukocyte elastase inhibitor for the in vitro diagnosis of colorectal cancer |
05/27/2010 | US20100129826 Double stranded RNA receptor (dsRNA-R) and methods relating thereto |
05/27/2010 | US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
05/27/2010 | US20100129814 Method for separation and characterization of microorganisms using identifier agents |
05/27/2010 | US20100129813 Compositions and methods for detecting food-borne pathogens |
05/27/2010 | US20100129809 INHIBITORS OF Rv0256c |
05/27/2010 | US20100129806 Regulation of cell survival by hsp90 and ip6k2 |
05/27/2010 | US20100129804 Spink1 as a prostate cancer marker and uses thereof |
05/27/2010 | US20100129795 Agents and methods for spectrometric analysis |
05/27/2010 | US20100129794 Magnetic Polymer Particles |
05/27/2010 | US20100129793 Composite particles |
05/27/2010 | US20100129791 cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product |
05/27/2010 | US20100129787 Agents and methods for spectrometric analysis |
05/27/2010 | US20100129786 Agents and methods for spectrometric analysis |
05/27/2010 | US20100129785 Agents and methods for spectrometric analysis |
05/27/2010 | US20100129502 Food tray device and method |
05/27/2010 | US20100129499 Breads |
05/27/2010 | US20100129438 Methods and Compositions for the Treatment and Prevention of HIV Infection Using TRIM5ALPHA |
05/27/2010 | US20100129409 Novel Prostate Kallikrein Allergen |
05/27/2010 | US20100129391 Immunogenic compositions comprising mycobacterium tuberculosis polypeptides and fusions thereof |
05/27/2010 | US20100129388 Protective proteins of s. agalactiae, combinations thereof and methods of using the same |
05/27/2010 | US20100129387 Pharmaceutical composition containing the nmb0606 protein |
05/27/2010 | US20100129386 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support |
05/27/2010 | US20100129378 Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction |
05/27/2010 | US20100129376 Osteopontin Specific Antibodies and Methods of Use Thereof |
05/27/2010 | US20100129374 Mammalian Cell Membrane Proteins; Related Reagents |
05/27/2010 | US20100129367 Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such |
05/27/2010 | US20100129360 Antibodies against human interleukin-13 and uses therefor |
05/27/2010 | US20100129346 Anti-C5aR Antibodies With Improved Properties |
05/27/2010 | US20100129345 Screening method for prokinetic agent |
05/27/2010 | US20100129336 Stabilized bacterial formulation |
05/27/2010 | US20100129318 Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses |
05/27/2010 | US20100129312 Infant formula containing an aroma composition for use as fragrance |
05/27/2010 | US20100129291 Nicotinic desensitizers and methods of selecting, testing, and using them |
05/27/2010 | US20100129289 Compositions and methods for the detection of vulnerable plaque |
05/27/2010 | US20100127165 Mass spectromety with selective ion filtration by digital thresholding |
05/27/2010 | US20100126911 Method For Using Native Bitumen Markers To Improve Solvent-Assisted Bitumen Extraction |
05/27/2010 | US20100126884 Analyte Sensor with Insertion Monitor, and Methods |
05/27/2010 | US20100126862 Multichannel preparative electrophoresis system |
05/27/2010 | US20100126856 Analyte Test Instrument Having Improved Versatility |
05/27/2010 | US20100126287 Pharmaceutical analysis apparatus and method |
05/27/2010 | US20100126253 Method for determining the alcohol concentration of fuel that can be fed to combustion in a motor vehicle |
05/27/2010 | DE202010002407U1 Testkoffer zur einfachen Bestimmung des Capsaicin-Gehalts von Lebensmitteln Test case for the simple determination of the capsaicin content in food |
05/27/2010 | DE202010001404U1 Schablone für Petrischalen Template for Petri dishes |
05/27/2010 | DE102009044594A1 Drahtloses Gerät zur Messung des Chloridgehalts im Schweiß für die Anwendung bei der Erkennung von zystischer Fibrose Wireless device to measure the chloride content in the welding for use in the detection of cystic fibrosis |
05/27/2010 | DE102008058514A1 Screening device for estimation/prediction of e.g. solubility characteristics, of pharmaceutical substance in pharmaceutical industry, has distribution/mixing mechanism that is formed and dimensioned to immerse in release volumes |
05/27/2010 | DE102008057866A1 Sample device for stool samples, has cap part with cone-shaped sealing attachment piece inserted into insertion opening of casing under flexible expansion, where attachment piece is brought into sealing contact with inner wall of casing |
05/27/2010 | DE102008053909A1 Gasdetektor Gas detector |
05/27/2010 | CA2744434A1 Methods, devices and kits for detecting or monitoring acute kidney injury |
05/27/2010 | CA2744340A1 Method of determining pegylated blood coagulation factor activity in a silica-based activated partial thromboplastin time assay |
05/27/2010 | CA2744331A1 Analyte detection assay |
05/27/2010 | CA2744251A1 Salmonella marker vaccine |
05/27/2010 | CA2744151A1 Metabolic syndrome and hpa axis biomarkers for major depressive disorder |
05/27/2010 | CA2744003A1 Biosensor for detecting multiple epitopes on a target |
05/27/2010 | CA2743907A1 Methods of determining polydispersity and/or molecular weight distribution of a polyethylene glycol sample |
05/27/2010 | CA2743570A1 Method for determining the risk of pre-eclampsia |
05/27/2010 | CA2743244A1 Semiconductor nanoparticle-based light emitting devices and associated materials and methods |
05/27/2010 | CA2742792A1 Prediction and prevention of preeclampsia |
05/26/2010 | EP2189793A1 Method for regenerating a biosensor |
05/26/2010 | EP2189792A2 Apparatus for separating and/or analysing several molecular targets in a solution in a complex mixture |
05/26/2010 | EP2189791A2 Microarrays and uses therefor |
05/26/2010 | EP2189790A1 Method for quantification of titer of neurotoxin-neutralizing antibody |
05/26/2010 | EP2189789A1 Method and device for checking the freshness of a fish |
05/26/2010 | EP2189788A1 Method for quantification of steroid hormone |
05/26/2010 | EP2189783A1 Waveguide grid structure and optical measuring assembly |
05/26/2010 | EP2189779A2 Measuring element, device for fabrication of at least one measuring element; storage and coding device for at least one measuring element |
05/26/2010 | EP2189537A1 Detection and treatment of schizophrenia |
05/26/2010 | EP2189527A1 Cancer diagnosis kit and cancer diagnosis method |
05/26/2010 | EP2189526A1 Antibody binding specifically to tdp-43 aggregate |
05/26/2010 | EP2189523A1 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives |
05/26/2010 | EP2189503A1 Novel nucleic acid derivative into which given compound has been introduced and method for producing the same |
05/26/2010 | EP2189475A2 Fibroblast growth factor-like polypeptides |
05/26/2010 | EP2189470A1 Tumor antigens |
05/26/2010 | EP2189468A1 Method for modification of nucleotides in nucleic acid, and nucleic acid having modified nucleotide therein |
05/26/2010 | EP2189220A1 Vessel for nucleic acid analysis |
05/26/2010 | EP2189166A1 Methods and materials for treating and diagnosing kallikrein-6 related inflammatory conditions |
05/26/2010 | EP2189164A1 Salmonella marker vaccine |
05/26/2010 | EP2189162A1 Methods for the treatment of cellular proliferative disorders |
05/26/2010 | EP2188636A1 Differentiation of different causes of right heart failure |
05/26/2010 | EP2188635A1 Quantification of analytes using accelerator mass spectrometry |
05/26/2010 | EP2188634A1 Fluorescence resonance energy transfer detection with nanoparticles |
05/26/2010 | EP2188633A1 Detecting hepatitis b virus |
05/26/2010 | EP2188632A1 Bacterial vaginosis apparatus and diagnostic methods |
05/26/2010 | EP2188631A1 Antigen exposing micelle and unordered aggregate |
05/26/2010 | EP2188630A2 Methods and compositions related to synergistic responses to oncogenic mutations |
05/26/2010 | EP2188629A1 Native gp41 assay |
05/26/2010 | EP2188628A2 Improved quality assurance system and method for point-of-care testing |
05/26/2010 | EP2188627A1 Test strip container |
05/26/2010 | EP2188625A1 Method and device for determining the chemical oxygen requirement of water or waste water |